138 related articles for article (PubMed ID: 21682979)
1. Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge.
van Ingen J; Aarnoutse R; de Vries G; Boeree MJ; van Soolingen D
Int J Tuberc Lung Dis; 2011 Jul; 15(7):990-2. PubMed ID: 21682979
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Cavusoglu C; Karaca-Derici Y; Bilgic A
Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
[TBL] [Abstract][Full Text] [Related]
3. Investigation of cross-resistance between rifampin and rifabutin in Mycobacterium tuberculosis complex strains.
Uzun M; Erturan Z; Anğ O
Int J Tuberc Lung Dis; 2002 Feb; 6(2):164-5. PubMed ID: 11931417
[TBL] [Abstract][Full Text] [Related]
4. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
Yang B; Koga H; Ohno H; Ogawa K; Fukuda M; Hirakata Y; Maesaki S; Tomono K; Tashiro T; Kohno S
J Antimicrob Chemother; 1998 Nov; 42(5):621-8. PubMed ID: 9848446
[TBL] [Abstract][Full Text] [Related]
5. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
[TBL] [Abstract][Full Text] [Related]
6. Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.
ElMaraachli W; Slater M; Berrada ZL; Lin SY; Catanzaro A; Desmond E; Rodrigues C; Victor TC; Crudu V; Gler MT; Rodwell TC
Int J Tuberc Lung Dis; 2015 Oct; 19(10):1222-6. PubMed ID: 26459537
[TBL] [Abstract][Full Text] [Related]
7. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
8. [Cross-resistance between rifampin and rifabutin in multidrug resistant Mycobacterium tuberculosis complex strains].
Gao L; Xiao HP; Hu ZY; Cui ZL; Lu JM; Shen XN
Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):333-5. PubMed ID: 22883990
[TBL] [Abstract][Full Text] [Related]
9. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658
[TBL] [Abstract][Full Text] [Related]
10. Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin.
McNerney R; Kiepiela P; Bishop KS; Nye PM; Stoker NG
Int J Tuberc Lung Dis; 2000 Jan; 4(1):69-75. PubMed ID: 10654647
[TBL] [Abstract][Full Text] [Related]
11. [Detection and characteristics of rpoB gene mutations in rifampicin-resistant clinical strains of M. tuberculosis].
Generozov EV; Al'tshuler ML; Govorun VM; Lopukhin IuM; Golyshevskaia VI; Chernousova LN; Khomenko AG
Probl Tuberk; 1999; (2):39-42. PubMed ID: 10420750
[TBL] [Abstract][Full Text] [Related]
12. Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia.
Sintchenko V; Chew WK; Jelfs PJ; Gilbert GL
Pathology; 1999 Aug; 31(3):257-60. PubMed ID: 10503273
[TBL] [Abstract][Full Text] [Related]
13. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains].
Chikamatsu K; Mizuno K; Yamada H; Mitarai S
Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
[TBL] [Abstract][Full Text] [Related]
15. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey.
Sanders M; Van Deun A; Ntakirutimana D; Masabo JP; Rukundo J; Rigouts L; Fissette K; Portaelst F
Int J Tuberc Lung Dis; 2006 Feb; 10(2):178-83. PubMed ID: 16499257
[TBL] [Abstract][Full Text] [Related]
16. Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey.
Senol G; Erbaycu A; Ozsöz A
J Chemother; 2005 Aug; 17(4):380-4. PubMed ID: 16167516
[TBL] [Abstract][Full Text] [Related]
17. rpoB mutations as an epidemiologic marker in rifampin-resistant Mycobacterium tuberculosis.
Chaves F; Alonso-Sanz M; Rebollo MJ; Tercero JC; Jimenez MS; Noriega AR
Int J Tuberc Lung Dis; 2000 Aug; 4(8):765-70. PubMed ID: 10949329
[TBL] [Abstract][Full Text] [Related]
18. [Characterization of rpoB mutation in rifampin - resistant clinical Mycobacterium tuberculosis isolates from China].
Huang H; Jin Q; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):231-5. PubMed ID: 11802970
[TBL] [Abstract][Full Text] [Related]
19. Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
Farhat MR; Sixsmith J; Calderon R; Hicks ND; Fortune SM; Murray M
J Antimicrob Chemother; 2019 Jun; 74(6):1477-1483. PubMed ID: 30793747
[TBL] [Abstract][Full Text] [Related]
20. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
